Filter
2637
Filtered Results: 2637
Text search:
vaccine
supply
Featured
Recommendations
298
New Publications
720
Language
Document type
No document type
1226
Studies & Reports
487
Guidelines
423
Strategic & Response Plan
181
Manuals
126
Fact sheets
85
Situation Updates
46
Training Material
37
Resource Platforms
13
Brochures
6
Infographics
3
Online Courses
3
App
1
Countries / Regions
India
123
Global
115
Kenya
79
Liberia
72
Nigeria
71
Sierra Leone
68
Ethiopia
61
Uganda
57
South Africa
50
Ghana
44
Africa
43
Nepal
42
Western and Central Europe
41
Congo, Democratic Republic of
39
Zambia
38
Malawi
36
Tanzania
33
Ukraine
32
Syria
32
Latin America and the Carribbean
32
Bangladesh
32
Myanmar / Burma
29
Rwanda
28
Philippines
22
Haiti
22
South Sudan
22
Guinea
21
West and Central Africa
21
Brazil
21
East and Southern Africa
20
Zimbabwe
19
Mozambique
19
South–East Asia Region
19
Russia
18
Middle East and North Africa
17
Namibia
17
Yemen
17
Senegal
16
Pakistan
16
Lesotho
15
Eastern Europe
15
Eastern Europe and Central Asia
13
Asia
12
Burkina Faso
11
Sudan
11
Cameroon
10
Cambodia
10
Botswana
10
Indonesia
10
Afghanistan
8
Venezuela
8
Western Pacific Region
8
Germany
7
Central African Republic
7
Somalia
6
Benin
5
Laos
5
Moldova
5
Mali
5
Eswatini/ Swaziland
5
Colombia
4
Paraguay
4
Lebanon
4
Chad
4
Thailand
3
Turkey
3
Togo
3
Jordan
3
Vietnam
3
Papua New Guinea
3
Iraq
3
Madagascar
3
North Macedonia
2
Timor Leste/ East Timor
2
China
2
Chile
2
Albania
2
Burundi
2
Peru
2
Guinea-Bissau
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Sri Lanka
2
Georgia
2
Angola
2
Tajikistan
1
Mexico
1
Gambia
1
Canada
1
Fiji
1
Kyrgyzstan
1
Niger
1
Bulgaria
1
USA
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
United Kingdom
1
Portugal
1
Spain
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1105
Clinical Guidelines
210
Key Resources
138
Public Health
126
Women & Child Health
124
Pharmacy & Technologies
40
Capacity Building
21
Annual Report MEDBOX
2
Toolboxes
COVID-19
468
Rapid Response
132
AMR
128
TB
121
HIV
114
Ebola & Marburg
108
Pharmacy
82
Conflict
79
Planetary Health
60
NTDs
59
Global Health Education
54
Caregiver
51
Refugee
45
Health Financing Toolbox
45
Cholera
42
Polio
38
Natural Hazards
35
Mental Health
18
NCDs
15
Zika
14
Specific Hazards
8
Disability
8
Typhoon
3
Malaria
2
South Sudan
1
20 January 2021
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati...
The effective vaccine management (EVM) workshop, jointly organized by WHO and UNICEF, was attended by participants from 13 countries, who reviewed the various EVM benchmarks, identified the gaps in policies, guidelines, SOPs and job aids, and developed respective country action plans to fill these g...
This presentation presents the issues we confront in deciding how to communicate to the public that COVID-19 vaccine recommendations reflect the state of scientific knowledge.
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor or VVM should be handled at the vaccination site, to ensure that safe and potent vaccines are administered.
This document has been updated: 31 August 2021
In its report from 2014, the Working Group outlines the various factors influencing vaccine acceptance or refusal, and what can be done to create social norms around vaccine acceptance and to encourage the general public regarding the necessity of vaccination.
